LY2456302   Click here for help

GtoPdb Ligand ID: 9194

Synonyms: CERC-501 | CERC501 | JNJ-67953964 | JNJ67953964 | LY-2456302
Compound class: Synthetic organic
Comment: LY2456302 is a potent small molecule, centrally-penetrant, selective antagonist of the κ opioid receptor, with potential antidepressant-like effects [2]. It is claimed in patent WO2009094260 [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 55.56
Molecular weight 418.21
XLogP 5.5
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Cc1cc(C)cc(c1)C1CCCN1Cc1ccc(cc1)Oc1ccc(cc1F)C(=O)N
Isomeric SMILES Cc1cc(C)cc(c1)[C@@H]1CCCN1Cc1ccc(cc1)Oc1ccc(cc1F)C(=O)N
InChI InChI=1S/C26H27FN2O2/c1-17-12-18(2)14-21(13-17)24-4-3-11-29(24)16-19-5-8-22(9-6-19)31-25-10-7-20(26(28)30)15-23(25)27/h5-10,12-15,24H,3-4,11,16H2,1-2H3,(H2,28,30)/t24-/m0/s1
InChI Key ZHPMYDSXGRRERG-DEOSSOPVSA-N
References
1. Diaz BN, Mckinzie DL, Mitch CH, Pedregal-Tecero C. (2009)
Kappa selective opioid receptor antagonist.
Patent number: WO2009094260. Assignee: Eli Lilly And Company. Priority date: 22/01/2008. Publication date: 30/07/2009.
2. Rorick-Kehn LM, Witkin JM, Statnick MA, Eberle EL, McKinzie JH, Kahl SD, Forster BM, Wong CJ, Li X, Crile RS et al.. (2014)
LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders.
Neuropharmacology, 77: 131-44. [PMID:24071566]